SHTG and FCS treatment market to evolve with the launch of ApoC-III inhibiting drugs, Olezarsen (Ionis) and ARO-APOC3 (Arrowhead). Clinical…
Find MoreWith increasing MedTech companies, their products, & regulatory approvals, we can see increased adoption of robotics in surgery.
Find MoreOrthopedic Implants Market is expected to grow at an immense pace. Companies are working to develop new implants to fulfill the demand
Find More100+ pharma companies are working to assess challenges & seek opportunities that could influence obesity treatment scenario in coming years.
Find MoreImmuno-oncology (I-O) therapeutics, despite yielding effective outcomes, remain associated with a risk of failure & adverse side effects.
Find MoreThe applications of Artificial Intelligence (AI) In Drug Commercialization is growing at an unprecedented rate. It provides several benefits
Find MoreOwning to evolution of genomic profiling technologies, cancer biomarkers are becoming increasingly relevant in management of cancer patients.
Find MoreBMS has established a comprehensive treatment strategy, with CELMODs replacing REVLIMID in earlier lines of multiple myeloma treatment.
Find MoreBurn is one of the most severe and rapidly growing burdens worldwide, leading to a very high number of mortality and morbidity yearly. It can have intense physical, socioeconomic, and psychological consequences on the person and their family. As per the latest assessment by DelveInsight, incident cases of burns req...
Find MoreWith a robust pipeline aiming to address the underserved market, the future of acute ischemic stroke treatment market holds much promise.
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.